This exhibit and its contents are intended to be viewed only by licensed healthcare professionals (HCPs). If you are not a licensed healthcare professional you are not allowed to access the relevant exhibit and you are instructed to return to the main exhibit hall.
This section may contain information about investigational compounds and/or investigational uses of approved products. The safety and efficacy of these investigational compounds or investigational uses of approved products have not been established nor approved.
Our study on the improved survival and cure rates after allo-#bmt for #ALL in Denmark in the last two decades presented at #EHA2021 is now out in Leukemia & Lymphoma. A population-based study thanks to the collaboration between @Rigshospitalet and @AUHdk http://www.tandfonline.com/eprint/HAS5TFYPEWDDPBUJYWGA/full?target=10.1080/10428194.2021.1992620
It's the first live day for the Highlights of Past #EHA (HOPE) Latin America. With tailored #EHA2021 content, this #EHAHOPE is meant for Latin America based professionals in #hematology.
You can still register for free to attend the live sessions.
The Highlights of Past #EHA (HOPE) Latin America platform is now open. Organized in concert with regional partners, discover #EHA2021 content on #AML, #CLL, #hemoglobinpathies, #BMF, #multiplemyeloma & more. Register for free:
The Highlights of Past #EHA (HOPE) Middle East & North Africa live days start today. This unique opportunity offers curated #EHA2021 content to professionals in #hematology based in the MENA region.
Not yet registered for #EHAHOPE? Sign up for the event: